Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Other Accumulated Expenses (2016 - 2025)

TrueBlue (TBI) has disclosed Other Accumulated Expenses for 17 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 39.08% to $4.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.2 million, a 39.08% decrease, with the full-year FY2025 number at $4.2 million, down 39.08% from a year prior.
  • Other Accumulated Expenses was $4.2 million for Q4 2025 at TrueBlue, down from $9.6 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $12.6 million in Q2 2022 to a low of $4.2 million in Q4 2025.
  • A 5-year average of $8.4 million and a median of $8.8 million in 2021 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: plummeted 48.15% in 2024, then surged 88.09% in 2025.
  • TrueBlue's Other Accumulated Expenses stood at $7.5 million in 2021, then surged by 45.03% to $10.9 million in 2022, then decreased by 4.76% to $10.4 million in 2023, then tumbled by 32.75% to $7.0 million in 2024, then tumbled by 39.08% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for TBI's Other Accumulated Expenses are $4.2 million (Q4 2025), $9.6 million (Q3 2025), and $10.1 million (Q2 2025).